The influence of cyclosporin alone, or cyclosporin and methotrexate, on the incidence of mixed haematopoietic chimaerism following allogeneic sibling bone marrow transplantation for severe aplastic anaemia
Tóm tắt
Từ khóa
Tài liệu tham khảo
McCann SR, Passweg JR, Storb R, Deeg HJ . HLA-identical sibling bone marrow transplantation to treat severe aplastic anemia. In: Schrezenmieir H, Bacigalupo A (eds). Aplastic Anemia. Pathophysiology and Treatment. Cambridge University Press: Cambridge, 2000, pp 230–257.
Tichelli A, Schrezenmeier H, Bacigalupo A . Immunosuppressive treatment of aplastic anemia. In: Schrezenmeier H, Bacigalupo A (eds). Aplastic Anemia. Pathophysiology and Treatment. Cambridge University Press: Cambridge, 2000, pp 154–196.
Bacigalupo A, Brand R, Oneto R, Bruno B, Socie G, Passweg J et al. Treatment of severe aplastic anemia: bone marrow transplantation compared with immunosuppression therapy – The European Group for Blood and Marrow Transplatation experience. Semin Hematol 2000; 37: 69–80.
McCann SR, Lawler M . Mixed chimerism; detection and significance following BMT. Bone Marrow Transplant 1993; 11: 91–94.
Sullivan KM, Agura E, Anasetti C, Appelbaum F, Badger C, Bearman S et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 1991; 28: 250–259.
Huss R, Deeg HJ, Gooley T, Bryant E, Leisenring W, Clift R et al. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myeloid leukaemia. Bone Marrow Transplant 1996; 18: 767–776.
McCann SR, Bacigalupo A, Gluckman E, Hinterberger W, Hows J, Ljungman P et al. Graft rejection and second bone marrow transplants for acquired aplastic anaemia: a report from the Aplastic Anaemia Working Party of the European Bone Marrow Transplant Group. Bone Marrow Transplant 1994; 13: 233–237.
Passweg JR, Socié G, Hinterberger W, Bacigalupo A, Biggs JC, Camitta BM et al. Bone Marrow Transplantation for severe aplastic anemia: has outcome improved? Blood 1997; 90: 858–864.
Storb R, Etzioni R, Anasetti C, Appelbaum FR, Buckner CD, Bensigner E et al. Cyclophosphamide combined with antthymocyte globulin in preparation for allogeneic bone marrow transplants in patients with aplastic anemia. Blood 1994; 84: 941–949.
Gluckman E, Horowitz MM, Champlin RE, Hows JM, Bacigalupo A, Biggs JC et al. Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome. Blood 1992; 76: 269–275.
Storb R, Deeg HJ, Farewell V, Doney K, Appelbaum F, Beatty P et al. Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of graft-versus-host disease. Blood 1986; 68: 119–125.
Storb R, Sanders JE, Pepe M, Anasetti C, Appelbaum FR, Buckner CD et al. Graft-versus-host disease prophylaxis with methotrexate/cyclosporine in children with severe aplastic anemia treated with cyclophosphamide and HLA-identica lmarrow grafts. Blood 1991; 76: 1144–1145.
Storb R, Leisenring W, Anasetti C, Allelbaum FR, Buckner CD, Bensinger W et al. Long-term follow up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin. Blood 1997; 98: 3890–3891.
Locatelli F, Bruno B, Zecca M, Van-Lint MT, McCann S, Arcese E et al. Cyclosporin A and short term methotrexate versus cyclosporin A as graft-versus-host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO-EBMT trial. Blood 2000; 96: 1690–1697.
Camitta B, Thomas ED, Nathan DG, Gale RP, Kopecky KJ, Rappeport JM et al. A prospective study of androgens and bone marrow transplantation for the treatment of severe aplastic anemia. Blood 1979; 53: 504–514.
Lawler M, Humphries P, McCann SR . Evaluation of mixed chimerism by in vitro amplification of dinucleotide repeat sequences using the polymerase chain reaction. Blood 1991; 77: 2504–2514.
Molloy K, Goulden N, Lawler M, Cornish J, Oakhill A, Pamphilon D et al. Patterns of haemopoietic chimerism following bone marrow transplantation for childhood leukaemia from volunteer unrelated donors. Blood 1996; 87: 3027–3031.
Lawler M, McCann SR . Polymerase chain reaction based methods for assessing chimerism following allogeneic bone marrow transplantation. In: Cotter SE, Totowa JN (eds). Methods in Molecular Medicine, Molecular Diagnosis of Cancer. Humana Press Inc.: Abingdon, UK, 1996, pp 105–120.
Hill RS, Petersen FB, Storb R, Appelbaum FR, Downey K, Dahlberg S et al. Mixed hematologic chimerism after allogeneic transplantation for severe aplastic anemia is associated with a higher risk of graft rejectionand a lessened incidence of acute graft-versus-host disease. Blood 1986; 67: 811–816.
Storb R, Longton G, Anasetti C, Appelbaum FR, Beatty P, Bensinger W et al. Changing trends in marrow transplantation for aplastic anemia. Bone Marrow Transplant 1992; 10: 45–52.
Locasciulli A, van't Veer L, Bacigalupo A, Hows J, Van Lint MT, Gluckman E et al. Treatment with marrow transplantation or immunosuppression of childhood acquired severe aplastic anemia; a report from the EBMT SAA Working Party. Bone Marrow Transplant 1990; 6: 211–217.
Bacigalupo A . Bone marrow transplantation for severe aplastic anemia from HLA identical siblings. Hematologica 1999; 1: 2–4.
Gowing H, Lawler M, McCann SR, Bacigalupo A, for the severe aplastic anemia working party of the EBMT. Chimerism studies following allogeneic bone marrow transplantation for severe aplastic anemia may help to predict those patients at higher risk of graft rejection. Exp Hematol 1998; 26: 784, 376a.
McGlave PB, Haake R, Miller W, Kim T, Kersey J, Ramsay NKC . Therapy of severe aplastic anemia in young adults and children with allogeneic bone marrow transplantation. Blood 1987; 70: 1325–1330.
Gluckman E, Socié G, Devergie M, Bourdeau-Esperou H, Traineau R, Cosset JM . Bone marrow transplantation in 107 patients with severe aplastic anemia using cyclophosphamide and thoraco-abdominal irradiation for conditioning therapy: long-term follow up. Blood 1991; 78: 2451–2455.
Champlin RE, Ho WG, Nimer SD, Gajewski JG, Selch M, Burnison M et al. Bone marrow transplantation for severe aplastic anemia. Effects of a preparative regimen of cyclophosphamide-low-dose-total-lymphoid irradiation and posttransplant Cyclosporine-methotrexate therapy. Transplantation 1990; 49: 720–724.